ABBV
AbbVie insider trading
3 Form 4 filings by 3 AbbVie insiders, accepted by the SEC between Oct 2, 2026 and Nov 12, 2026: 1 reporting sales (about $11,925,738 in total at the reported prices), 0 reporting open-market purchases, and 2 reporting awards, tax withholding, exercises or other transactions.
- Nov 125:00 PM ET
- Oct 25:00 PM ET
- Oct 25:00 PM ET
Times are when the SEC accepted the filing, in US Eastern time. Each note summarizes what the filing reports; none says whether to buy or sell.
Disclosures
- Editor holdings
- The editor holds no position in any company named on this page. As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links on this page.
General education, the same for every reader. Not a recommendation to buy, sell or hold any security, and it doesn't consider your situation.